| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |